# Safety Study of an Oral Vaccine to Prevent Seasonal Influenza

> **NCT01688297** · PHASE1 · COMPLETED · sponsor: **Vaxart** · enrollment: 61 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** VXA-A1.1 Oral Vaccine
- **BIOLOGICAL:** VXA Placebo Tablet

## Key facts

- **NCT ID:** NCT01688297
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-05
- **Final completion:** 2015-04
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688297, "Safety Study of an Oral Vaccine to Prevent Seasonal Influenza". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01688297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*